Please assess the completion status of the following clinical trial:

Trial Title: Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Acute Promyelocytic Leukemia (APL)~Exclusion Criteria:~* \> 14

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 14 Years
- Healthy Volunteers: f

Study Arms:
- DNR+Ara-c(Ara-C group) (Type: ACTIVE_COMPARATOR): patients in this group were treated with DNR+Ara-C in consolidation
- DNR(No Ara-C group) (Type: EXPERIMENTAL): patients in this group were treated with DNR alone in consolidation

Based on this trial design, predict the completion outcome and termination type (if applicable).